- Home
- Analyse des applications
- Hemangiom'App
- Hemangiom'App Vs. Neurobalance
Hemangiom'App vs Neurobalance Utilisation & Stats
Hemangiom’app is designed for caregivers of infants who have been prescribed an oral treatment for
proliferating Infantile Hemangioma.
Hemangiom’App is a digitalization of the caregiver guide, designed to help you manage your infant’s
treatment plan through support and guidance, with these key features:
- View Caregiver guide for Education and Treatment compliance
- Create medical history and receive reminders
- Track your medical appointments
- Access your medication report to easily share with your team
This app is intended for the exclusive use of caregivers 18 years of age and older. The Hemangiom’ App is
not intended to provide treatment decisions or replace the care and advice of a licensed healthcare
provider. If you have any questions about this information, be sure to discuss them with your healthcare
provider.
- Apple App Store
- Gratuit
- Médical
Classement dans le store
- -
Sistema revolucionario para restaurar salud cerebral y ayudar a pacientes con Autismo, TDAH, Dislexia y otros problemas madurativos.
Trabajamos con niños y adultos para restaurar la conexión somato-cerebral en pacientes con:
- TDAH o TDA
- Trastornos del Espectro Autista
- Ansiedad / Depresión
- Tourette’s
- Aspergers
- Trastorno Obsesivo Compulsivo
- Dislexia
- Trastorno Bipolar
- Otros trastornos mentales, conductuales y de aprendizaje
- Apple App Store
- Gratuit
- Santé & Fitness
Classement dans le store
- -
Comparaison des classements Hemangiom'App vs. Neurobalance
Comparez l'évolution du classement de Hemangiom'App au cours des 28 derniers jours à celle de Neurobalance.
Rank
Aucune donnée disponible
Comparaison des classements Hemangiom'App et Neurobalance par pays
Comparez l'évolution du classement de Hemangiom'App au cours des 28 derniers jours à celle de Neurobalance.
Aucune donnée à afficher
Comparez avec n'importe quel site grâce à notre essai gratuit
Hemangiom'App VS.
Neurobalance
23écembre d, 2024